High intensity exercise or omega 3s which one reduces heart failure risk Dr. Nandita Mohan24 March 2022 5:30 PM ISTA year of high-intensity interval training appeared to benefit obese middle-aged adults at a high risk of heart failure, but omega-3 fatty acid...
Icosapent Ethyl Cost-Effective Treatment Option for high-risk patients with hypertriglyceridemia MD Bureau24 Feb 2022 9:00 AM ISTThe Reduction of Cardiovascular Events With Icosapent Ethyl-Intervention Trial (REDUCE-IT) demonstrated the efficacy of icosapent ethyl (IPE) for...
Total VLDL Concentration may increase Blood Viscosity and microvascular complications in diabetics: Study MD Bureau11 Feb 2022 10:30 AM ISTMultiple studies support an association between elevated triglyceride levels with microvascular complications of diabetes mellitus. A recent study...
Novel omega-3 krill oil reduces triglyceride levels in hypertriglyceridemia: JAMA Medha Baranwal13 Jan 2022 10:45 AM ISTUSA: A recent study reported that a novel krill oil–derived ω-3 formulation may reduce triglyceride (TG) levels and is safe and well-tolerated in...
Risk reduction in persistent hypertriglyceridemia: ACC guidelines Medha Baranwal31 July 2021 11:30 AM ISTUSA: The American College of Cardiology (ACC) has released clinical guidance on atherosclerotic cardiovascular disease (ASCVD) risk reduction in...
Management of Severe Hypertriglyceridemia with Insulin Infusion in COVID-19: Case Series MD Bureau24 April 2021 4:21 AM ISTRapid onset of severe hypertriglyceridemia was quickly recognized in critical COVID-19 patients. In a recent case series, researchers have reported...
Indian's death in Maldives in 2016: AIIMS tells HC he died due to natural causes Medical Dialogues Bureau19 April 2019 9:00 AM ISTThe board members have "unanimously concluded" that the "cause of the death was Cerebro pulmonary oedema secondary to heart failure with associated...
Zydus gets USFDA nod for clinical trials of Sarolitazar Meghna A Singhania19 Nov 2015 2:30 PM ISTNew Delhi: Zydus Cadila has received US health regulator's nod to initiate phase II clinical trials of Sarolitazar, its new drug for treating high fat...
